L-Cysteine Supplementation Increases Adiponectin Synthesis and Secretion, and GLUT4 and Glucose Utilization by Upregulating Disulfide Bond A-like Protein Expression Mediated by MCP-1 Inhibition in 3T3-L1 Adipocytes Exposed to High Glucose
Overview
Affiliations
Adiponectin is an anti-diabetic and anti-atherogenic adipokine; its plasma levels are decreased in obesity, insulin resistance, and type 2 diabetes. An adiponectin-interacting protein named disulfide bond A-like protein (DsbA-L) plays an important role in the assembly of adiponectin. This study examined the hypothesis that L-cysteine (LC) regulates glucose homeostasis through the DsbA-L upregulation and synthesis and secretion of adiponectin in diabetes. 3T3L1 adipocytes were treated with LC (250 and 500 µM, 2 h) and high glucose (HG, 25 mM, 20 h). Results showed that LC supplementation significantly (p < 0.05) upregulated the DsbA-L, adiponectin, and GLUT-4 protein expression and glucose utilization in HG-treated adipocytes. LC supplementation significantly (p < 0.05) promoted the secretion of total and HMW adiponectin secretion in HG-treated adipocytes. In addition, LC significantly (p < 0.05) decreased ROS production and MCP-1 secretion in HG-treated cells. We further investigated whether MCP-1 has any role of LC on DsbA-L expression and adiponectin levels in 3T3-L1 cells. Treatment with LC prevented the decrease in DsbA-L, adiponectin, and GLUT-4 expression in 3T3L1 adipocyte cells exposed to MCP-1. Thus, this study demonstrates that DsbA-L and adiponectin upregulation mediates the beneficial effects of LC on glucose utilization by inhibiting MCP-1 secretion in adipocytes and provides a novel mechanism by which LC supplementation can improve insulin sensitivity in diabetes.
New insights of DsbA-L in the pathogenesis of metabolic diseases.
Li S, Wan J, Peng Z, Huang Q, He B Mol Cell Biochem. 2024; 479(12):3293-3303.
PMID: 38430301 DOI: 10.1007/s11010-024-04964-8.
Skeletal Muscle CSE Deficiency Leads to Insulin Resistance in Mice.
Xu M, Liu X, Bao P, Wang Y, Zhu X, Liu Y Antioxidants (Basel). 2022; 11(11).
PMID: 36358588 PMC: 9687043. DOI: 10.3390/antiox11112216.
Huang Y, Chang Y, Cheng C, Wu C, Liao W, Tsai F Genes (Basel). 2020; 12(1).
PMID: 33374471 PMC: 7823606. DOI: 10.3390/genes12010017.
Parsanathan R, Jain S Free Radic Res. 2018; 52(2):288-303.
PMID: 29378451 PMC: 6181233. DOI: 10.1080/10715762.2018.1431626.
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
Achari A, Jain S Int J Mol Sci. 2017; 18(6).
PMID: 28635626 PMC: 5486142. DOI: 10.3390/ijms18061321.